GSK256066 |
Inhibitor of PDE4B
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PDE4B |
|
|
Inhibitor
Cellular activity range includes 0.01 nM, solubility may be limiting at higher concentrations
0.1-10 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
>1000-fold selective versus PDEs 1–3 and 5–7
Potency Cellular
In Vitro
PDE4B
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1016/j.bmcl.2009.04.012
In Vivo Validations
Rat
Dose: 1 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
1.1 h (IV)
Systemic clearance:
39 mL/min/kg
Fb :
0% (PO)
DOI Reference: 10.1016/j.bmcl.2009.04.012
Dose:
Route of delivery:
Intratracheal
Volume of Distribution at Steady-State:
0.8 L/kg
DOI Reference: 10.1016/j.bmcl.2009.04.012
Negative Control Compounds
cpd 3
Orthogonal Probes def
R(-)Rolipram
Chemical Information
| Molecular Formula | C27H26N4O5S |
| SMILEs | COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1 |
| InChI | InChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30) |
| Molecular weight | 518.16 Da |
| AlogP | 3.92892 |
| HBond acceptors | 9 |
| HBond donors | 3 |
| Atoms | 63 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.